LONDON BROKER RATINGS: Stifel raises Rentokil to 'buy' from 'hold'
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More
| Price | 303.50p on 12-10-2026 at 08:41:55 |
|---|---|
| Change | 0.50p 0.17% |
| Buy | 303.60p |
| Sell | 303.40p |
| Last Trade: | Sell 1,730.00 at 303.50p |
| Day's Volume: | 559,065 |
| Last Close: | 303.00p |
| Open: | 304.20p |
| ISIN: | GB00B082RF11 |
| Day's Range | 300.90p - 305.00p |
| 52wk Range: | 293.50p - 506.80p |
| Market Capitalisation: | £7.64b |
| VWAP: | 302.89576p |
| Shares in Issue: | 2.52b |
Rentokil Initial (RTO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 1,730 | 303.50p | Automatic Execution |
09:41:48 - 12-Oct-26 |
| Sell* | 75 | 303.50p | Automatic Execution |
09:41:48 - 12-Oct-26 |
| Buy* | 500 | 303.50p | Automatic Execution |
09:40:52 - 12-Oct-26 |
| Buy* | 771 | 303.50p | Automatic Execution |
09:40:52 - 12-Oct-26 |
| Buy* | 282 | 303.50p | Automatic Execution |
09:40:52 - 12-Oct-26 |
| Buy* | 1,730 | 303.50p | Automatic Execution |
09:40:52 - 12-Oct-26 |
| Buy* | 1,211 | 303.50p | Automatic Execution |
09:40:52 - 12-Oct-26 |
| Sell* | 74 | 303.40p | Automatic Execution |
09:40:37 - 12-Oct-26 |
| Sell* | 1 | 303.30p | Ordinary |
09:40:18 - 12-Oct-26 |
| Sell* | 344 | 303.40p | Automatic Execution |
09:38:54 - 12-Oct-26 |
Rentokil Initial (RTO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th Oct 2026 11:15 am | RNS | Holding(s) in Company |
| 30th Sep 2026 10:25 am | RNS | Holding(s) in Company |
| 22nd Sep 2026 7:00 am | RNS | Sale of SOLitude Lake Management, LLC |
| 27th Aug 2026 3:00 pm | RNS | Interim Dividend – Pence Sterling Amount Payable |
| 13th Aug 2026 9:30 am | RNS | Organisational Changes & Leadership Appointments |
| 4th Aug 2026 10:30 am | RNS | Holding(s) in Company |
| 3rd Aug 2026 1:00 pm | RNS | Director/PDMR Shareholding |
| 30th Jul 2026 7:00 am | RNS | Half-year Financial Report |
| 16th Jul 2026 10:00 am | RNS | Director Declaration |
| 21st May 2026 7:00 am | RNS | Appointment of CEO, North America |